{"schema_version":"1","generated_at":"2026-11-09T06:24:30.558Z","data_as_of":null,"url":"https://www.findmykol.com/kol/richard-tenglin","json_url":"https://www.findmykol.com/kol/richard-tenglin/profile.json","record_kind":"basic","profile_kind":"clinical","person":{"slug":"richard-tenglin","name":"Richard Tenglin","credential":"MD","specialty":"Medical Oncology","specialty_raw":"Medical Oncology","therapeutic_area":"Oncology","therapeutic_areas":["Oncology"],"institution":"Rapid City Regional Hospital","institution_url":"https://www.findmykol.com/institution/rapid-city-regional-hospital","city":"Rapid City","state":"SD","region":{"label":"Midwest","url":"https://www.findmykol.com/region/midwest"}},"identifiers":{"npi":"1164522751","openalex":"A5091659110"},"summary":"Richard Tenglin is an Oncology physician affiliated with Rapid City Regional Hospital. OpenAlex indexes 17 publications with 281 citations (h-index 7).","overview":null,"focus":{"indications":[],"research_topics":["Oncology"]},"scholarship":{"works_count":17,"cited_by_count":281,"h_index":7,"latest_activity_year":2022,"source":"works"},"publications":{"total":17,"shown":5,"withheld":12,"matched_by":"OpenAlex author record","recent":[{"title":"Randomized Phase II Study of Two Doses of Pixantrone in Patients with Metastatic Breast Cancer (NCCTG N1031, Alliance)","year":2022,"journal":"The Oncologist","source_url":"https://doi.org/10.1093/oncolo/oyab065","status":"verified"},{"title":"Pregnancies during and after trastuzumab and/or lapatinib in patients with human epidermal growth factor receptor 2–positive early breast cancer: Analysis from the NeoALTTO (BIG 1‐06) and ALTTO (BIG 2‐06) trials","year":2018,"journal":"Cancer","source_url":"https://doi.org/10.1002/cncr.31784","status":"verified"},{"title":"Pregnancies during and following trastuzumab (T) and/or lapatinib (L) in patients (pts) with HER2-positive (HER2+) early breast cancer (EBC): Analysis from the NeoALTTO (BIG 1-06) and ALTTO (BIG 2-06) trials.","year":2018,"journal":"Journal of Clinical Oncology","source_url":"https://doi.org/10.1200/jco.2018.36.15_suppl.10065","status":"verified"},{"title":"Randomized phase II study of two doses of pixantrone in patients with metastatic breast cancer (N1031, Alliance).","year":2012,"journal":"Journal of Clinical Oncology","source_url":"https://doi.org/10.1200/jco.2012.30.15_suppl.1083","status":"verified"},{"title":"Accelerated Hyperfractionated Radiation Therapy Following Lumpectomy and Axillary Lymph Node Dissection in Patients with Stage I and II Breast Cancer Receiving Adriamycin-based Chemotherapy: A NCCTG Pilot Study","year":2008,"journal":"International Journal of Radiation Oncology*Biology*Physics","source_url":"https://doi.org/10.1016/j.ijrobp.2008.06.729","status":"verified"}],"source":"works"},"similar":[{"name":"Carl June","slug":"carl-june","institution":"University of Pennsylvania","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/carl-june","json_url":"https://www.findmykol.com/kol/carl-june/profile.json"},{"name":"Rainer Storb","slug":"rainer-storb","institution":"University of Washington","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/rainer-storb","json_url":"https://www.findmykol.com/kol/rainer-storb/profile.json"},{"name":"Christina Fitzmaurice","slug":"christina-fitzmaurice","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/christina-fitzmaurice","json_url":"https://www.findmykol.com/kol/christina-fitzmaurice/profile.json"},{"name":"Beth Karlan","slug":"beth-karlan","institution":"University of California, Los Angeles","specialty":"Gynecologic Oncology","url":"https://www.findmykol.com/kol/beth-karlan","json_url":"https://www.findmykol.com/kol/beth-karlan/profile.json"}],"coverage":{"note":"A basic directory record. Sections absent here were not yet checked for this person, so absence means not yet looked, never none found.","not_yet_checked":["funding","congress","network","presence","recognition"]},"not_included":{"note":"This document is the public layer: neutral facts cited to their source. Judgments (influence tier, archetype, trajectory commentary) and the itemized rows past each section's public teaser are account features and are not served here or to crawlers.","withheld_rows":{"publications":12}},"sources":{"identity":{"name":"NPPES (CMS)","url":"https://npiregistry.cms.hhs.gov","provides":"Identity, specialty and practice location for every U.S. clinician"},"works":{"name":"OpenAlex","url":"https://openalex.org","provides":"Citations, h-index, research topics, most-cited works and congress abstracts"}},"methodology_url":"https://www.findmykol.com/about#methodology"}